Benzamide derivatives and uses related thereto

Details for Australian Patent Application No. 2006259349 (hide)

Owner Amgen Inc.

Inventors Degraffenreid, Michael R.; McMinn, Dustin L.; Powers, Jay P.; He, Xiao; Julian, Lisa; Yan, Xuelei; Rew, Yosup; Sun, Daqing

Agent Shelston IP

Pub. Number AU-B-2006259349

PCT Pub. Number WO2006/138508

Priority 60/691,244 17.06.05 US

Filing date 15 June 2006

Wipo publication date 28 December 2006

Acceptance publication date 27 October 2011

International Classifications

C07C 235/42 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07C 237/22 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

C07C 255/24 (2006.01) Carboxylic acid nitriles

C07C 255/31 (2006.01) Carboxylic acid nitriles

C07C 255/44 (2006.01) Carboxylic acid nitriles

C07C 255/46 (2006.01) Carboxylic acid nitriles

C07C 255/60 (2006.01) Carboxylic acid nitriles

C07C 317/36 (2006.01) Sulfones

C07D 211/16 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/18 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/22 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/34 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/38 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/52 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/60 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/64 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

7 February 2008 PCT application entered the National Phase

  PCT publication WO2006/138508 Priority application(s): WO2006/138508

27 October 2011 Application Accepted

  Published as AU-B-2006259349

17 November 2011 Application for Amendment

  The nature of the amendment is: Amend the name of the inventor to read DeGraffenreid, Michael R.; McMinn, Dustin L.; Powers, Jay P.; He, Xiao; Julian, Lisa; Yan, Xuelei; Rew, Yosup and Sun, Daqing. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

8 March 2012 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read DeGraffenreid, Michael R.; McMinn, Dustin L.; Powers, Jay P.; He, Xiao; Julian, Lisa; Yan, Xuelei; Rew, Yosup and Sun, Daqing

15 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006259352-Use of HIF 1alfa modulators for treatment of cancer

2006259348-Use of sanglifehrin in HCV